Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | ESR2 | Q92731 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 1.00 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ESR1 | P03372 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | STAT3 | P40763 | 1/20 | 0.61 |
| ▸ | MKNK2 | Q9HBH9 | 3/20 | 0.60 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.60 |
| ▸ | ACVRL1 | P37023 | 4/20 | 0.59 |
| ▸ | F13A1 | P00488 | 1/20 | 0.57 |
| ▸ | TGM2 | P21980 | 1/20 | 0.57 |
| ▸ | KDR | P35968 | 5/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zeranol SCHEMBL9592548 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Taleranol SCHEMBL29554859 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Taleranol SCHEMBL343276 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL31122084 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL109174 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL10773090 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL29554783 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL2602612 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL28985464 | 0.99 | LMNA (0.98) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| Zeranol SCHEMBL28584517 | 0.95 | LMNA (0.91) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| US-20230383269-A1 | TETRAMERIC ALPHA/BETA HYDROLASE VARIANTS WITH INCREASED TEMPERATURE STABILITY AND METHODS OF USING AND PRODUCING THEREOF | DSM Austria GmbH (AT) | 2023-11-30 | — | — | US | disclosed |
| EP-4225901-A1 | TETRAMERIC ALPHA/BETA HYDROLASE VARIANTS WITH INCREASED TEMPERATURE STABILITY AND METHODS OF USING AND PRODUCING THEREOF | DSM Austria GmbH (AT) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022073649-A1 | TETRAMERIC ALPHA/BETA HYDROLASE VARIANTS WITH INCREASED TEMPERATURE STABILITY AND METHODS OF USING AND PRODUCING THEREOF | ERBER AKTIENGESELLSCHAFT (AT) | 2022-04-14 | — | — | WO | disclosed |
| CN-114292828-A | Tetrameric alpha/beta hydrolase variants with improved temperature stability and methods of use and production thereof | 爱尔伯股份公司 | 2022-04-08 | — | — | CN | disclosed |
| EP-2292585-B1 | Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound | APTUIT WEST LAFAYETTE LLC (US) | 2016-04-27 | — | — | EP | disclosed |
| EP-2417118-B1 | A PROCESS FOR MANUFACTURING ZERANOL | INTERVET INT BV (NL) | 2016-01-27 | — | — | EP | disclosed |
| US-8920559-B2 | Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound | APTUIT (WEST LAFAYETTE), LLC (US) | 2014-12-30 | — | — | US | disclosed |
| US-8674120-B2 | Process for manufacturing zeranol | INTERVET INTERNATIONAL B.V. (NL) | 2014-03-18 | — | — | US | disclosed |
| US-8350085-B2 | Cocrystallization | NEW FORM PHARMACEUTICALS INC. (US) | 2013-01-08 | — | — | US | disclosed |
| WO-2010115478-A1 | A PROCESS FOR MANUFACTURING ZERANOL | INTERVET INTERNATIONAL B.V. (NL) | 2010-10-14 | — | — | WO | disclosed |
| US-7767708-B2 | Growth stimulant compositions | SCHERING-PLOUGH ANIMAL HEALTH CORP. (US) | 2010-08-03 | — | — | US | disclosed |
| US-20090281195-A1 | NOVEL COCRYSTALLIZATION | S.S.C.I., INC. (US) | 2009-11-12 | — | — | US | disclosed |
| US-20090075962-A1 | GROWTH STIMULANT COMPOSITIONS | SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (US) | 2009-03-19 | — | — | US | disclosed |
| US-7452555-B2 | Cocrystallization | S.S.C.I., INC. (US) | 2008-11-18 | — | — | US | disclosed |
| US-20070287194-A1 | Screening For Solid Forms By Ultrasound Crystallization And Cocrystallization Using Ultrasound | S.S.C.I., INC | 2007-12-13 | — | — | US | disclosed |
| US-20070088508-A1 | Cocrystallization methods | APTUIT (WEST LAFAYETTE), LLC | 2007-04-19 | — | — | US | disclosed |
| WO-2007038524-A2 | COCRYSTALLIZATION METHODS | SSCI, INC. (US) | 2007-04-05 | — | — | WO | disclosed |
| WO-2000025743-A2 | IMPROVED GROWTH STIMULANT COMPOSITIONS | SCHERING CORPORATION (US) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230383269-A1 | TETRAMERIC ALPHA/BETA HYDROLASE VARIANTS WITH INCREASED TEMPERATURE STABILITY AND METHODS OF USING AND PRODUCING THEREOF | HDHD5, NCEH1, DNPH1 | LMNA 2031/4885SMN1; SMN2 2071/4885ESR2 2799/4885 |
| US-20090075962-A1 | GROWTH STIMULANT COMPOSITIONS | GHRHR, GHSR, AREG | LMNA 2924/4885SMN1; SMN2 2306/4885ESR2 672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.